LiverRisk score (LRS) predicts long-term liver-related outcomes in a cohort of Veterans without evidence of liver disease

Hepatology 2026

View at publisher
Authors: Rubén Hernáez, Yan Liu, Miquel Serra-Burriel, Kavish R. Patidar, Adrià Julià i Juanola, Isabel Graupera, Elisa Pose, Núria Fabrellas, Avegail G. Flores, Jennifer R. Kramer, Fasiha Kanwal, Pere Ginès
DOI: 10.1097/hep.0000000000001669
Cited by: 1
References: 25

Abstract

BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing and disproportionately affects Hispanics. The LiverRisk score (LRS), a non-invasive stratification tool, could enhance early identification of patients at risk for liver disease; however, it has not been validated in a large U.S. Veteran cohort with sufficient liver-related outcomes. APPROACH: We conducted a retrospective cohort study of Veterans Health Administration (VHA) patients from 1999 to 2023. Individuals with chronic liver disease, viral hepatitis, or missing LRS values were excluded using laboratory and ICD-10 data. Patients were classified into minimal (LRS

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Hepatitis C virus research

Publication details

Journal / source
Hepatology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
84
Issue
3
Pages
805–816
Publication date
12 January 2026
Language
EN